search for: receptor

...-rich flanking regions N-terminal,Cysteine-rich flanking regions C-terminal LEUCINE-RICH TRANSMEMBRANE PROTEINS Biological process unclassified - A_51_P100174 NM_008613.2 - MEIOSIS-SPECIFIC NUCLEAR STRUCTURAL PROTEIN 1 Developmental processes Meiosis A_51_P100218 NM_134198.1 Vomeronasal receptors type 1,GPCRs rhodopsin-like superfamily VOMERONASAL PHEROMONE RECEPTOR Signal transduction,Sensory perception Cell surface receptor mediated signal transduction,Pheromone response A_51_P100227 NM_023579.4 HEAT,Importin-betas N-terminal,Armadillo-like helical IMPORTIN BETA-3,IMPORTIN BETA I...

Hi, I have the following data frame: > print(mydatframe) __DATAFRAME__ V1 V2 V3 1 1007_s_at DDR1 discoidin domain receptor tyrosine kinase 1 2 1053_at RFC2 replication factor C (activator 1) 2, 40kDa 3 117_at HSPA6 heat shock 70kDa protein 6 (HSP70B') __END__ Is there a way to create a hash with V2 as Key and V3 as its value? - Gundala Viswanath Jakarta - Indonesia

Hi, I have the following data file to be parsed and captured as a data frame: __DATA__ #GDS_ID GENE_NAME GENE_DESCRIPTION GENE_FUNCTION 1007_s_at | DDR1 | discoidin domain receptor tyrosine kinase 1 | protein-coding 1053_at | RFC2 | replication factor C (activator 1) 2, 40kDa | protein-coding 117_at | HSPA6 | heat shock 70kDa protein 6 (HSP70B') | protein-coding __END__ In particular it is separated by " | " , namely - space, bar, space. However I tried this w...

Dear all, Here is my code which am using to combine 5th column from different data sets. Here is the function to do my job genesymbol.append.file <-NULL gene.column <- NULL readGeneSymbol <- function(files,genesymbol.column=5){ for(i in fnames){ temp <- read.table(fnames,header=T,sep="\t",stringsAsFactors=F,quote="\"")

Dear R-helpers: I am trying to fit a multivariate Cox proportional hazards model, modelling survival outcome as a function of treatment and receptor status. The data look like below: # structure of the data str(sample.data) List of 4 $ survobj : Surv [1:129, 1:2] 0.8925+ 1.8836+ 2.1191+ 5.3744+ 1.6099+ 5.2567 0.2081+ 0.2108+ 0.2683+ 0.4873+ ... ..- attr(*, "dimnames")=List of 2 .. ..$ : NULL .. ..$ : chr [1:2] "time&quo...

Hello. I'm running some asterisks in a small voip provider in Brazil and we're having some problems with a analogic channel bank. When I make calls using analogic extensions, I have a crystal clear quality, but the receptor have a lot of noise and echo. We tested the situation using SIP, E1 links, GSM links, analogic trunks (FXO ports) and we always have the same symptons My configurations for /etc/asterisk/chan_dahdi.conf and /etc/dahdi/system.conf: http://www.pastebin.org/56678 Versions of software: CentOS 5.4 f...

...= zcol[i])) grid.circle(x = x[i], y = y[i], r = .5 * scale, default.units = "native") } } k=levelplot(signif(z,3), scales = list(x = list(rot = 45)), col.regions=col.sch, panel = panel.corrgram.2, label = num.circ, xlab="", ylab="", main=paste(output,"receptor response")) print(k) -- Best, Dat Mai PhD Rotation Student Albert Einstein College of Medicine [[alternative HTML version deleted]]

...list, Has anyone created a version of SSmicmen that allows testing for group differences? The basic Michaelis-Menten equation is: (Bmax * X) / (Kd + X). The nlme package allows modeling of random effects for Bmax and Kd as needed, but I curious how I can build in group differences? I have receptor binding data for strains of mice, and following Pinheiro and Bates' lead in their book, a random effort for animal differences in Bmax seems reasonable, within strain. However, I'd like a self-start function, or even just the equation above, modified to allow testing for strain diff...

...11 de marzo de 2022 fue publicada en el Diario Oficial de la Federaci?n la actualizaci?n de la NOM-001-SEMARNAT-2021 que sustituye a la NOM-001-SEMARNAT-1996, la cual entrar? el presente a?o y ser? obligatoria para las personas f?sicas o morales que realicen descargas de aguas residuales a cuerpos receptores de propiedad nacional, ya sea por amparo de un t?tulo de concesi?n o permiso de descarga otorgado por la autoridad. En la aplicaci?n de esta norma, se deber? de tomar en cuenta lo siguiente: los par?metros y l?mites permisibles entrar?n en vigor el 3 de abril de 2023 y, los par?metros y l?mites p...

To estimate saturation binding parameters Bmax and Kd in a receptor saturation binding experiment, I use the following nonlinear equation and the nls() function: bmax*X*dummy ------------ + ns*X + background = total binding kd+X where X is concentration, and dummy is an indicator to allow shared estimation of the nonspecific binding parameter ns. This equa...

...right direction i'd be really thankfull Cheers thanks in advance. -------------- next part -------------- NOTA CONFIDENCIAL: La informaci?n contenida en este E-mail es confidencial y s?lo puede ser utilizada por la persona o la compa??a a la cual est? dirigido y/o por el emisor. Si no es el receptor autorizado, cualquier retenci?n, difusi?n, distribuci?n o copia de este mensaje es prohibida y ser? sancionada por la ley. Si por error recibe este mensaje, favor reenviarlo y borrar el mensaje recibido inmediatamente. CONFIDENTIAL NOTE: The information in this E-mail is intended to be confidenti...

Hi I' ve just installed TE410P and asterisk-0.7.2 from tar.gz on fedora core 1. When i start asterisk it shows me this: /usr/lib/asterisk/modules/chan_zap.so: undefined symbol: ast_pickup_call Apr 19 16:52:32 WARNING[-1085304704]: loader.c:358 load_modules: Loading module chan_zap.so failed! Where do i look, how can i debug? Thanks in advance Jorge Verastegui G RedCetus S.R.L

[This email is either empty or too large to be displayed at this time]

Dear R-helpers: I am trying to fit a multivariate Cox proportional hazards model, modelling survival outcome as a function of treatment and receptor status. The data look like below: # structure of the data str(sample.data) List of 4 $ survobj : Surv [1:129, 1:2] 0.8925+ 1.8836+ 2.1191+ 5.3744+ 1.6099+ 5.2567 0.2081+ 0.2108+ 0.2683+ 0.4873+ ... ..- attr(*, "dimnames")=List of 2 .. ..$ : NULL .. ..$ : chr [1:2] "time&quo...

...lum vitae, and contact information for references to : Dr. Fabienne Venet: fabienne.venet at chu-lyon.fr Dr. Julien Textoris : julien.textoris at biomerieux.com Dr. Sophie Blein : sophie.blein at biomerieux.com Publications Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Demaret J, Villars-M?chin A, Lepape A, Plassais J, Vallin H, Malcus C, Poitevin-Later F, Monneret G, Venet F. Intensive Care Med. 2014 Aug;40(8):1089-96. Low-dose hydrocortisone reduces norepinephrine duration in severe burn patient...

...ed. Thanks for your help Uriel Quintana La informaci?n contenida en este correo electr?nico es confidencial y est? legalmente protegida. Est? dirigido solamente a la direcci?n de correo se?alada. El acceso a este correo electr?nico por cualquier otra persona, No est? autorizado. Si Ud. no es el receptor deliberado de este correo electr?nico, cualquier difusi?n, copia o distribuci?n est? prohibida y puede ser ilegal.? Si lo ha recibido por error, por favor notifique al emisor e inmediatamente? b?rrelo de forma permanente y destruya cualquier copia impresa. En caso de que el correo est? dirigido a a...

...d&uid=a6430e8be957614fc0de15c1041eeb18&mid=43. Esta mensagem está de acordo com a legislação Portuguesa (Decreto-Lei nº 7/2004, de 7 de Janeiro) sobre o envio de mensagens comerciais: Qualquer mensagem deverá estar claramente identificada com os dados do emissor e deverá proporcionar ao receptor a hipótese de ser removido da lista. Se você não quiser mais receber mensagens desta lista, clique http://www.almasoma.pt/lists/?p=unsubscribe&uid=a6430e8be957614fc0de15c1041eeb18. [[alternative HTML version deleted]]

...preferred. About AVEO AVEO Pharmaceuticals (NASDAQ: AVEO) integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics. The company's lead product, Tivozanib, is an oral, triple VEGF receptor inhibitor with potential for a best-in-class profile. Tivozanib is currently being investigated in a global, randomized Phase 3 clinical trial called TIVO-1 <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ave opharma.com%2Ffor_patients%2F&esheet=6299494&lan=en_US...

Hello, I have a seemingly simple problem that a tab-delimited file can't be read in. > annoTranscripts <- read.table("matched.txt", sep = '\t', stringsAsFactors = FALSE) Error in scan(file, what, nmax, sep, dec, quote, skip, nlines, na.strings, : line 5933 did not have 12 elements However, all lines do have 12 columns. > lines <-

...//rcytoscape.systemsbiology.net/versions/current/gallery/TCGA/subnet.TCGA.02.0014.png This portrays 1) gene expression (green: under-expression; red: over-expression) 2) copy number (blue: high, black: low) 3) gene type (node shape: hexagons are kinases, arrows are ligands, diamonds are receptors, circles for everything else) 4) mutation status (not SNPs, but non-synonymous amino acid substitutions) 5) in the context of gene relationships, from KEGG A vignette for a larger version of this network is nearly complete. The Cytoscape network map is created from data and R code. -...